HTG Molecular Diagnostics HTGM
$ 0.48
-20.0%
Annual report 2022
added 03-30-2023
Country |
USA |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Mr. John Lubniewski |
Employees in the company |
108 |
Shares |
889 K |
Market Cap[1] |
$ 1.06 M |
EBITDA (LTM) |
$ -19.8 M |
P/E (LTM) |
-1.53 |
P/S (LTM) |
1.24 |
EPS (LTM) |
-2.36 |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.